Entering text into the input field will update the search result below

Verrica Pharmaceuticals moves forward with VP-102

Nov. 27, 2019 7:17 AM ETVerrica Pharmaceuticals Inc. (VRCA) StockVRCABy: Clark Schultz, SA News Editor
  • Verrica Pharmaceuticals (NASDAQ:VRCA) announces that its new drug application for a proprietary topical therapy for the treatment of molluscum contagiosum has been accepted by the FDA.
  • The company says the PDUFA goal date assigned by the FDA for the NDA on VP-102 is July 13, 2020.
  • Management calls the acceptance of the NDA for review the next step toward bringing patients and their caregivers a safe and effective topical therapy for the common, highly contagious viral skin disease.
  • Source: Press Release

Recommended For You

More Trending News

About VRCA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VRCA--
Verrica Pharmaceuticals Inc.